Journal
CLINICAL AND EXPERIMENTAL DERMATOLOGY
Volume 36, Issue 6, Pages 585-589Publisher
WILEY
DOI: 10.1111/j.1365-2230.2011.04108.x
Keywords
-
Categories
Funding
- UK National Health Service (NHS)
- Medical Research Council [G1000417] Funding Source: researchfish
- National Institute for Health Research [CL-2008-06-002] Funding Source: researchfish
- MRC [G1000417] Funding Source: UKRI
Ask authors/readers for more resources
This review summarizes key clinical findings from 5 guidelines and 21 systematic reviews on psoriasis published or indexed in the period November 2009 to October 2010. The highlights include the British Association of Dermatologists guidelines on the use of biological interventions in psoriasis, and guidelines on the efficacy and use of acitretin. Biological therapies were reviewed for use in specific patient groups (such as those with hepatitis C) and from a health-economics perspective. Another systematic review focused on outcome measures used to assess the severity of psoriasis. Finally, comorbidities including cardiovascular risk were the topic of four systematic reviews.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available